Spherical Crystallization as a New Platform for Particle Design Engineering
Autor Yoshiaki Kawashimaen Limba Engleză Hardback – 2 iun 2019
This book describes the principles and applications of the spherical crystallization technique, from the standpoint of its inventor. After an introduction on the history of particle design engineering and nanotechnology, the concept of spherical crystallization itself is clearly explained. Attention then turns to the application of spherical crystallization in pharmaceutical processes. It is explained how the technique can provide physicochemical properties suitable for direct tableting of active pharmaceutical ingredients and how it has enabled the development of a novel particulate design platform from single to complex system. Subsequent chapters describe the roles of polymeric spherical crystallization in the preparation of novel microspheres, microballoons for drug delivery systems (DDS) and the development of biocompatible and biodegradable poly(D,L-lactide-co-glycolide) (PLGA) nanospheres. The various applications of PLGA nanospheres composite within oral-, pulmonary-, transdermal DDS and cosmetics are fully discussed. Finally, future perspectives are presented on use of the technology in the design and industrial-scale manufacture of new drug delivery systems, highlighting how a continuous pharmaceutical process that meets US Food and Drug Administration quality requirements should soon be introduced.
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 887.51 lei 38-44 zile | |
Springer Nature Singapore – 14 aug 2020 | 887.51 lei 38-44 zile | |
Hardback (1) | 1063.29 lei 3-5 săpt. | |
Springer Nature Singapore – 2 iun 2019 | 1063.29 lei 3-5 săpt. |
Preț: 1063.29 lei
Preț vechi: 1296.70 lei
-18% Nou
Puncte Express: 1595
Preț estimativ în valută:
203.51€ • 213.96$ • 169.27£
203.51€ • 213.96$ • 169.27£
Carte disponibilă
Livrare economică 07-21 decembrie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9789811367854
ISBN-10: 981136785X
Pagini: 122
Ilustrații: XVII, 118 p. 110 illus., 32 illus. in color.
Dimensiuni: 155 x 235 mm
Greutate: 0.34 kg
Ediția:1st ed. 2019
Editura: Springer Nature Singapore
Colecția Springer
Locul publicării:Singapore, Singapore
ISBN-10: 981136785X
Pagini: 122
Ilustrații: XVII, 118 p. 110 illus., 32 illus. in color.
Dimensiuni: 155 x 235 mm
Greutate: 0.34 kg
Ediția:1st ed. 2019
Editura: Springer Nature Singapore
Colecția Springer
Locul publicării:Singapore, Singapore
Cuprins
Introduction.- Concept of spherical crystallization.- Paradigm shifted pharmaceutical process introduced by spherical crystallization.- Particulate-design platform developed by the Advanced Spherical Crystallization System.- Development of Novel Microsphere and Microballoon DDS by Polymeric Spherical Crystallization.- Development of PLGA Nanopsphere for Drug Delivery System (DDS) Prepared by Polymeric Spherical Crystallization.- Application of PLGA NSs to cosmetics.- Future perspectives of PLGA nanospheres for advanced DDSs and continuous preparation systems for spherical crystallizers.
Notă biografică
[Current Position and Affiliations]
Contract Professor of Pharmaceutical Technology, Faculty of Science, Aichi Gakuin University,
Kusumoto, Chikusaku, Nagoya 464- 8650, Japan
Emeritus Professor of Gifu Pharmaceutical University, Daigaku Nishi, Gifu 501- 1113, Japan
[Fields and Areas of Specialization]
Particulate design engineering for drug delivery systems including spherical crystallization,
agglomeration, microencapsulation, nanocapsule
[Education]
1964, March B. Pharm. Nagoya City University, Japan
1966, March M. Pharm. Kyoto University, Japan
1970, January Ph. D. Kyoto University, Japan
[Position Held]
1969, April Assistant Professor, Gifu Pharmaceutical University
1972-74 Postdoctoral Fellow, National Research Council of Canada
1977 Invited Visiting Scientist, National Research Council of Cana
1978, April Associate Professor, Gifu Pharmaceutical University
1983, April Professor, Gifu Pharmaceutical University
1986 Invited Visiting Professor (JSPS), National University of Singapore
1991 Invited Visiting Professor, Shenyang Pharmaceutical University
[Award]
(1) The Most Promotive Research Work Award, 1986 from Pharmaceutical Society of Japan
(2) The 4th Upjohn Fellowship for Scientific Research 1990 for “Particle Design for Development of Novel Dosage Forms”
(3) The Science Award, 1992 from The Academy of Pharmaceutical Science and Technology, Japan
(4) The Conference Pharmaceutiques Barre 1993 from The Faculty of Pharmacy, University of Montreal (Canada)
(5) The 9th Annual Colorcon Award, 1995 from FIP (International Pharmaceutical Federation) Foundation for Education and Research
(6)
American Association Pharmaceutical Scientist (AAPS) Fellow (Seattle, 1996)(7) The Best Paper Award, 1997 from the Academy of Pharmaceutical Science Technology, Japan
(8) KONA Award, 1998 from the Hosokawa Powder Technology Foundation
(9) Science Award, 2000 from Gifu News Paper Press
(10) Pharmaceutical Sciences World Congress (PSWC) Research Achievement Award, 2004
(11) Swiss Galenic Pharmaceutical World Fellow, 2004
(12) International Fellow of the Academy of Pharmaceutical Science Technology, Japan, 2010
[Society Membership]
The Academy of Pharmaceutical Science and Technology, Japan (Council Member)
The Society of Powder Technology, Japan (President past, Chairman of The Division of Pharmaceutical Preparations and Particulate Design past)
The Association of Powder Process Industry and Engineering, Japan (Vice President past)
Pharmaceu
tical Society of Japan (Council Member, past)Japan Society of Drug Delivery System (Council Member)
International Pharmaceutical Federation, FIP (Board of Pharmaceutical Sciences)
Japan Society of Pharmaceutical Machinery and Engineering President past, Council Member)
American Association of Pharmaceutical Scientists (Fellow)
Controlled Release Society, and others
[Editor and Editorial Advisory Board]
S. T.P. Pharma Sciences J. Drug Delivery Sci. Technol.(Editor in Chief for Japan past)
Asian J. Pharm. Sci. Technol. (Editor in Chief for Japan past)
European Journal of Pharmaceutics and Biopharmaceutics (Pacific Rim Editor past)
Journal of Microencapsulation (Regional Editor past)
Powder Technology
Journal of Controlled Release
Advanced Powder Technology
The Chinese Pharmaceutical JournalChemical Pharmaceutical Bulletin (past)
Journal of The Society of Powder Technology, Japan (past)
Yakugaku Zasshi (past)
[Publication]
Original Research Papers, 306 Patents, 35
Textul de pe ultima copertă
This book describes the principles and applications of the spherical crystallization technique, from the standpoint of its inventor. After an introduction on the history of particle design engineering and nanotechnology, the concept of spherical crystallization itself is clearly explained. Attention then turns to the application of spherical crystallization in pharmaceutical processes. It is explained how the technique can provide physicochemical properties suitable for direct tableting of active pharmaceutical ingredients and how it has enabled the development of a novel particulate design platform from single to complex system. Subsequent chapters describe the roles of polymeric spherical crystallization in the preparation of novel microspheres, microballoons for drug delivery systems (DDS) and the development of biocompatible and biodegradable poly(D,L-lactide-co-glycolide) (PLGA) nanospheres. The various applications of PLGA nanospheres composite within oral-, pulmonary-, transdermal DDS and cosmetics are fully discussed. Finally, future perspectives are presented on use of the technology in the design and industrial-scale manufacture of new drug delivery systems, highlighting how a continuous pharmaceutical process that meets US Food and Drug Administration quality requirements should soon be introduced.
Caracteristici
Describes the principles and applications of the spherical crystallization technique from the standpoint of its inventor
Explains key developments in pharmaceutical manufacturing
Discusses the new US Food and Drug Administration philosophy
Explains key developments in pharmaceutical manufacturing
Discusses the new US Food and Drug Administration philosophy